Search JIC Articles:

FINAL DATA FROM THE SEISMIC TRIAL SUGGEST SAFETY, EFFICACY OF AUTOLOGOUS STEM-CELL THERAPY FOR TREATING CONGESTIVE HEART FAILURE

Final six-month, follow-up patient data presented today during the late-breaking clinical trial sessions at the American College of Cardiology, suggest MyoCell® myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy alone for improving heart function among patients with previously implanted cardiac devices who are experiencing congestive heart failure.

New Terumo Glidecath® Catheter Yashiro Tip Shape Improves Access to Celiac Artery: FEATURING UNIQUE SHAPED THREE-DIMENSIONALTIP DESIGN

Terumo Interventional Systems’ proven Glidecath Hydrophilic Coated catheter product line makes way for the Yashiro tip shape; a new, three-dimensional U-shape tip for optimal entry to the celiac trunk. T

Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation

The American Board of Internal Medicine (ABIM) will offer Interventional Cardiology Simulations, using Medical Simulation Corporation’s (MSC) SimSuite® technology, for credit toward completion of Maintenance of Certification. This is the first time ABIM is incorporating medical simulation technology into its programs to evaluate physician competence. T

Frost & Sullivan Lauds the Outstanding Product Quality of Guerbet’s Flagship X-ray Contrast Agent

Palo Alto, Calif. - September 20, 2007 - Frost & Sullivan selected Guerbet as the recipient of the 2007 North American Frost & Sullivan Product Quality Leadership Award for the superiority of its contrast media products. T

FIRST PATIENTS TREATED IN RENALGUARD™ INVESTIGATIONAL STUDY BY PLC MEDICAL SYSTEMS

FRANKLIN, Mass, March 16, 2007 --- PLC Medical Systems, Inc. (Amex: PLC), a company focused on innovative cardiac and vascular medical device-based technologies, announced the successful enrollment of the first patients in its FDA-approved clinical trial designed to evaluate the safety of its RenalGuard System™. Safety results were favorable, and there were no adverse renal events related to the device recorded.

Terumo Interventional Systems Launches Pinnacle® R/O II HiFlo for Superficial Access

Terumo Interventional Systems, a strategic business unit of medical device manufacturer Terumo Medical Corporation, has introduced an addition to its line of Pinnacle sheaths; the Pinnacle R/O II HiFlo Introducer Sheath. This product launch further advances Terumo’s leadership position in endovascular medicine.

Safety And Efficacy Of Drug-Eluting Stents Reaffirmed In NEJM Articles And Editorial

Boston Scientific Corporation welcomed the results of two studies and an editorial published The New England Journal of Medicine (NEJM), all of which reaffirmed the safety and efficacy of drug-eluting stents.

MELODIE Clinical Trial Reports Excellent Safety and Efficacy Results for Express™ Vascular LD Stent in the Treatment of Blocked Iliac Arteries

Boston Scientific Corporation announced 12-month data from its MELODIE clinical trial. The trial demonstrates the safety and efficacy of the Express™ Vascular LD Peripheral Pre-Mounted Balloon Expandable Stent in the treatment of narrowed or blocked iliac arteries. The trial was designed to prove the non-inferiority of the Express Vascular LD stent in comparison to the PALMAZ® Balloon Expandable Stent in the treatment of blocked iliac arteries. The Company made the announcement at the annual Paris Course on Revascularization (EuroPCR).